Ra Capital Management, L.P. - Director, 10%+ Owner at Acumen Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
Director, 10%+ Owner
Stock Symbol
ABOS on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Ra Capital Management, L.P. - trading volume in the past year for Acumen Pharmaceuticals, Inc.

Holdings reported by Ra Capital Management, L.P. for Acumen Pharmaceuticals, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 13,043,179 $45.3 M $3.47 Jul 21, 2023 Indirect
Stock Option (Right to Buy) 25,000 Jun 10, 2024 Indirect Common Stock

Transactions reported by Ra Capital Management, L.P. for Acumen Pharmaceuticals, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership